Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 181 - 190 of 245 for gsk. (0.07 seconds)

CBT 200 Rings Up Sixth Straight Loss. More details...
CBT 200 Drops 63 Points. More details...
Viral Therapy Is Coming Of Age. More details...
Biotech Makes A Big Gain. More details...
CBT 200 Makes Third Straight Big Gain. More details...
CBT 200 Adds On Another 5 Points. More details...
CBT 200 Gains More Than 2%. More details...
CBT 200 Drops 34 Points. More details...
Stock Sells Off On The News. More details...
CBT 200 Is Up 9 Points. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital